Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon
Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is
Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a
Quality Training All Treatment Modalities You, your staff, your patients in the comfort of your own office. Real hands on training! Our on-site consultant Joyce Vining RVT, LPN 25 years experience treating vein disease. Venous Ultrasound | Endovenous Ablation | Phlebectomy | Sclerotherapy Need Office Forms, Photos, and Patient Education?
Cook Medical announced that its Thoraco+ endovascular system has received Breakthrough Device designation from the FDA. The company describes Thoraco+ as a next- generation, off-the-shelf device in the Zenith platform, indicated for patients with thoracoabdominal aortic aneurysms (Crawford classification I-IV). It has four side branches for the celiac, superior mesenteric,
Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of AlucentNVS, the company’s natural vascular scaffolding device. According to the company, the ACTIVATE II trial will enroll up to 50 patients at up to
Koya Medical’s Dayspring compression system launched for lower extremity treatment of lymphedema and venous disorders
Koya Medical announced the United States commercial availability of its Dayspring active compression system for the treatment of lymphedema and venous diseases in the lower extremities. The company also announced that the Centers for Medicare & Medicaid Services (CMS) issued three new billing codes in accordance with the Healthcare Common
AngioDynamics, Inc. announced the launch of a new clinical study assessing the use of the company’s Auryon atherectomy system in the treatment of calcified lesions in below-the-knee (BTK) arteries. The company announced the commercial launch of the Auryon system in Sep. 2020. The investigator-initiated Auryon BTK study will be conducted
Center For Vein Restoration VISION 2022: March 11th-13th / Washington DC In-Person & Virtual Premier Clinical Convention. 10 + CME Credits. World-Renowned Speakers. 400+ In-Person Attendees and 1400 Virtual Attendees Anticipated. Please visit the VISION 2022 website [hyperlink the text; website is: https://web.cvent.com/event/c94e2be4-dc4c-42ee-92c2-d916e98e5ea8/summary or more information, including the conference agenda.
The 2022 Venous Symposium will be held from April 21–23, 2022 at the Sheraton New York Times Square Hotel. The Venous Symposium is the premier international conference on issues and treatment related to vein pathology. The symposium delivers practical education and updates on the current knowledge and management of venous